Clinical Trials Logo

Clinical Trial Summary

The goal of this randomized controlled trial is to compare the rebleeding rate in cirhotic patients with gastric variceal bleeding receiving balloon-occluded retrograde transvenous obliteration and endoscopic tissue glue injection. The main questions it aims to answer are: - Recurrent gastric variceal bleeding - Further decompensation of liver cirrhosis Participants will receive balloon-occluded retrograde transvenous obliteration and endoscopic tissue glue injection. Researchers will compare balloon-occluded retrograde transvenous obliteration and endoscopic tissue glue injection to see if the rebleeding rate associated with balloon-occluded retrograde transvenous obliteration is lower than that associated with endoscopic tissue glue injection.


Clinical Trial Description

Variceal bleeding is a severe complication of portal hypertension. Gastric variceal bleeding (GVB) is more severe than bleeding from esophageal varices. Gastric varices also have a higher risk of rebleeding than esophageal varices. Previous studies showed that endoscopic injection of cyanoacrylate was superior to endoscopic variceal ligation in the management of gastric variceal bleeding. Another study showed that transjugular intrahepatic portosystemic shunt had a lower rebleeding rate than endoscopic cyanoacrylate injection. However, transjugular intrahepatic portosystemic shunt (TIPS) is more invasive and carries a risk of development of hepatic encephalopathy and is usually preserved for uncontrolled variceal bleeding. Therefore, endoscopic cyanoacrylate injection is recommended as the treatment of choice for GVB. Balloon-occluded retrograde transvenous obliteration (BRTO) is a new therapy for gastric variceal bleeding. However, BRTO is associated with increased portal pressure and worsening of ascites, hepatohydrothorax, and esophageal varices. There are only a few retrospective studies comparing BRTO and endoscopic cyanoacrylate injection in the prevention of recurrent gastric variceal bleeding. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06106971
Study type Interventional
Source Kaohsiung Veterans General Hospital.
Contact Wen-Chi Chen, M.D
Phone +886 (07) 3468016
Email wcchen@vghks.gov.tw
Status Recruiting
Phase Phase 3
Start date June 28, 2018
Completion date June 2025

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04198259 - Interventional Devascularization Plus HVPG‐Guided Carvedilol Therapy vs TIPS N/A
Withdrawn NCT05859009 - Primary Prevention of Gastric Varices Bleed N/A
Not yet recruiting NCT06122792 - Preemptive TIPS for Gastric Variceal Bleeding in Patients With Cirrhosis N/A
Recruiting NCT05545475 - Safety of Anticoagulant Therapy After Tissue Glue for Gastric Varices
Recruiting NCT06370169 - EUS Guided Coil Embolization for Primary Prophylaxis of Gastric Varices N/A
Not yet recruiting NCT03853720 - Combined and Simultaneous Approach for the Treatment of High-risk Gastric Varices Using B-RTO and EVO N/A
Completed NCT05521685 - Impact of EUS Guided Treatment of Gastric Varices
Completed NCT03438916 - MRI to Assess the Effect of Non-selective Beta-blocker in Patients With Cirrhosis